微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 93.06% | -3.96% | 84.68% | 5/159 | -1.59% | 海创药业 | 99.57% | 行业排名> |
| 2025-06-30 | 50.39% | -48.58% | 2.11% | 70/159 | 15.28% | 海创药业 | 99.52% | 行业排名> |
| 2025-03-31 | 49.35% | -50.11% | -48.3% | 70/159 | 32.3% | 艾力斯 | 96.74% | 行业排名> |
| 2024-12-31 | 95.46% | 61.27% | -1.48% | 5/159 | 51.78% | 首药控股 | 98.96% | 行业排名> |
| 2024-09-30 | 96.9% | 57.41% | -1.12% | 2/159 | 22.81% | 迪哲医药 | 97.73% | 行业排名> |
| 2024-06-30 | 97.99% | 53.37% | -0.94% | 1/159 | 33.25% | 百利天恒 | 97.99% | 行业排名> |
| 2024-03-31 | 98.92% | 59.45% | 67.12% | 1/159 | 51.56% | 百利天恒 | 98.92% | 行业排名> |
| 2023-12-31 | 59.19% | -11.53% | -3.84% | 57/159 | 51.39% | 迈威生物 | 98.93% | 行业排名> |
| 2023-09-30 | 61.56% | -10.14% | -3.66% | 50/159 | 32.56% | 迈威生物 | 99.59% | 行业排名> |
| 2023-06-30 | 63.89% | -10.77% | 2.99% | 46/159 | 38.45% | 迈威生物 | 99.8% | 行业排名> |
| 2023-03-31 | 62.04% | 2% | -7.28% | 49/159 | 52.78% | 迈威生物 | 99.46% | 行业排名> |
| 2022-12-31 | 66.91% | -11.01% | -2.33% | 45/159 | 53.66% | 迈威生物 | 99.75% | 行业排名> |
| 2022-09-30 | 68.5% | 2% | -4.34% | 39/159 | 6.2% | 迈威生物 | 99.67% | 行业排名> |
| 2022-06-30 | 71.61% | -8.93% | -4.75% | 39/159 | 21.37% | 迈威生物 | 99.44% | 行业排名> |
| 2021-12-31 | 75.18% | -6.21% | -4.38% | 33/159 | 55.1% | 迈威生物 | 98.57% | 行业排名> |
| 2021-06-30 | 78.63% | 26.22% | -1.91% | 24/159 | 47.23% | 首药控股 | 99.93% | 行业排名> |
| 2020-12-31 | 80.16% | -0.98% | -0.98% | 22/159 | -145.9% | 艾力斯 | 99.41% | 行业排名> |
| 2019-12-31 | 80.95% | 2.5% | 2.5% | 16/159 | -1222.98% | 艾力斯 | 98.7% | 行业排名> |
| 2018-12-31 | 78.98% | 2% | 26.78% | 23/159 | -208.09% | 艾力斯 | 99.4% | 行业排名> |
| 2015-06-30 | 62.29% | 2% | 2% | 18/159 | 45% | 首药控股 | 99.94% | 行业排名> |